|
|
 |
|
|
|
| |
Matthew M. Ames, Ph.D.
Mayo Clinic
Mechanisms of Aminoflavone Selective Cytotoxicity |
|
|
| |
Nancy Carrasco,
M.D.
Albert Einstein College of Medicine
Diagnosis and Targeted Radio Iodide Therapy in Breast Cancer |
|
|
| |
Arul M. Chinnaiyan, M.D., Ph.D.
University of Michigan
Development of Breast Cancer Biomarkers Using DNA and Protein Microarray
Technologies |
|
|
| |
Gilbert Chu
M.D., Ph.D.
Stanford University School of Medicine
Predicting Breast Cancer Risk from Microarrays |
|
|
| |
John D. Minna, M.D.
U.T. Southwestern Medical Center at Dallas
Development of RNAi technology to knock down the expression of genes potentially
important in the pathogenesis of human breast, ovarian, and cervical cancer |
|
|
| |
Eric J. Stanbridge,
Ph.D.
University of California, Irvine
Molecular Genetic Analysis of Cervical Cancer Progression |
|
|
| |
Ajay Verma, M.D., Ph.D.
Uniformed Services University of the Health Sciences
Erythropoietin Signaling in Cervical Cancer |
|
|